Sign In
Get Clay Free →

Suggestions

    Jérôme Braudeau

    PhD in Neuroscience, Co-founder & CEO @ AgenT | Defeating Alzheimer's

    Jérôme Braudeau, Co-founder & CEO of AgenT

    Jérôme Braudeau is the Co-founder and CEO of AgenT, a biotechnology company dedicated to developing innovative therapies for age-related diseases, particularly Alzheimer's.36 He holds a PhD in Neuroscience and is focused on defeating Alzheimer's through his work at AgenT.46

    Professional Experience

    • Co-founder & CEO at AgenT (founded in March 2018)36
    • Previously worked as an AgenT1

    Education

    • PhD in Neuroscience467
    • Attended Université Paris-Est Créteil (UPEC)1

    Recent Activities

    • Gave a 1-hour talk in Porto, Portugal on the Future of Healthcare, Health, themes of his focus, Career and Leadership2
    • Participated in the BIOUS conference in San Diego5
    • Presented at the AD/PD 2024 conference on Alzheimer's research and innovation4

    Jérôme Braudeau is actively working to defeat Alzheimer's through his leadership at AgenT, a company he co-founded in 2018 with the ambition to contribute to the fight against this devastating disease.34

    Related Questions

    What are the main goals of AgenT in the fight against Alzheimer's?
    What innovative therapies is AgenT developing for age-related diseases?
    How did Jérôme Braudeau's background in neuroscience influence his leadership at AgenT?
    What was the focus of Jérôme Braudeau's talk in Porto, Portugal?
    How has AgenT-biotech evolved since its founding in 2018?
    Jérôme Braudeau
    Jérôme Braudeau, photo 1
    Jérôme Braudeau, photo 2
    Get intro to Jérôme
    Add to my network

    Location

    Greater Paris Metropolitan Region